Annual Total Liabilities
$58.70 M
+$10.27 M+21.21%
December 31, 2023
Summary
- As of February 12, 2025, NAMS annual total liabilities is $58.70 million, with the most recent change of +$10.27 million (+21.21%) on December 31, 2023.
- During the last 3 years, NAMS annual total liabilities has risen by +$42.95 million (+272.65%).
- NAMS annual total liabilities is now at all-time high.
Performance
NAMS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$60.33 M
+$1.08 M+1.82%
September 30, 2024
Summary
- As of February 12, 2025, NAMS quarterly total liabilities is $60.33 million, with the most recent change of +$1.08 million (+1.82%) on September 30, 2024.
- NAMS quarterly total liabilities is now -21.30% below its all-time high of $76.66 million, reached on March 31, 2024.
Performance
NAMS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NAMS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.2% | - |
| 3 y3 years | +272.6% | +24.6% |
| 5 y5 years | +272.6% | +24.6% |
NAMS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +418.9% | -21.3% | +433.3% |
| 5 y | 5-year | at high | +418.9% | -21.3% | +433.3% |
| alltime | all time | at high | +418.9% | -21.3% | +433.3% |
NewAmsterdam Pharma Company NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.33 M(+1.8%) |
| Jun 2024 | - | $59.25 M(-22.7%) |
| Mar 2024 | - | $76.66 M(+30.6%) |
| Dec 2023 | $58.70 M | $58.70 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $53.07 M(+9.6%) |
| Dec 2022 | $48.43 M(+328.1%) | $48.43 M(+38.7%) |
| Jun 2022 | - | $34.92 M(+208.7%) |
| Dec 2021 | $11.31 M(-28.2%) | $11.31 M |
| Dec 2020 | $15.75 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total liabilities?
- What is the all time high annual total liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual total liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV annual total liabilities?
The current annual total liabilities of NAMS is $58.70 M
What is the all time high annual total liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total liabilities is $58.70 M
What is NewAmsterdam Pharma Company NV annual total liabilities year-on-year change?
Over the past year, NAMS annual total liabilities has changed by +$10.27 M (+21.21%)
What is NewAmsterdam Pharma Company NV quarterly total liabilities?
The current quarterly total liabilities of NAMS is $60.33 M
What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total liabilities is $76.66 M